Zahrat Al Amal Medical Group

Zahrat Al Amal Medical Group, based in Riyadh, Saudi Arabia, provides a diverse range of medical services focused on patient-centered care and advanced medical technology, addressing the healthcare needs of various demographics within the region. Founded in 1986, Zahrat Al Amal Medical Group is a healthcare provider based in Riyadh, Saudi Arabia. The company has undergone operational enhancements and strategic expansions, recently acquired by Dividend Gate Capital and Abdulla Fouad Group in September 2025. The founders' history and other details about previous companies are not disclosed.

Zahrat Al Amal Medical Group offers a comprehensive range of healthcare services designed to address various medical needs within the Riyadh region. Their core offerings include general medicine, pediatrics, orthopedics, ophthalmology, dermatology, radiology, otorhinolaryngology, physiotherapy, dentistry, obstetrics and gynecology, urology, and internal medicine. Each department is equipped to deliver specialized care, with a focus on patient-centered service and advanced medical technology. The target clientele encompasses individuals seeking routine health care, families prioritizing children's development, and adults requiring specialized treatment for complex health issues.

Zahrat Al Amal Medical Group serves a diverse geographical market, primarily in urban centers within the Kingdom of Saudi Arabia, ensuring that quality healthcare is accessible to a wide array of patients. The revenue structure of Zahrat Al Amal Medical Group is driven by direct patient interactions and service delivery, primarily through fee-for-service models. Patients access healthcare services on a transactional basis, paying for specific consultations, treatments, and diagnostic tests as needed. The firm may offer packages for comprehensive care, which include multiple services at a bundled rate, appealing to families and individuals seeking extensive medical attention.

Each service is priced according to its complexity and the resources utilized, ensuring transparency in billing. As the company operates in a competitive healthcare market, maintaining a focus on service quality and patient satisfaction is essential for fostering long-term relationships with clients and generating consistent revenue streams. In September 2025, a majority stake in Zahrat Al Amal Medical Group was acquired by Dividend Gate Capital, Abdulla Fouad Group, and a consortium of strategic investors, facilitating plans for expansion and operational enhancements. The investment will be utilized for infrastructure development, improved operational efficiency, and broader clinical offerings.

A new medical center is also planned to broaden patient access while maintaining high standards of care.